Temporary Policy Regarding Preventive Controls and Foreign Supplier Verification Programs Food Supplier Verification Onsite Audit Requirements During the COVID-19 Public Health Emergency: Guidance for Industry; Availability, 17008-17009 [2020-05897]
Download as PDF
17008
Federal Register / Vol. 85, No. 59 / Thursday, March 26, 2020 / Rules and Regulations
lotter on DSKBCFDHB2PROD with RULES
of the complete final BPI document on
the next business day under paragraph
(c)(2)(ii) of this section. This paragraph
(f)(4)(ii) does not apply to service to pro
se parties or parties represented by a
non-APO-authorized representative.
(iii) For case and rebuttal briefs served
pursuant to paragraph (f)(3)(i) of this
section, service of BPI case and rebuttal
briefs will be deemed effectuated via
ACCESS. This paragraph (f)(4)(iii) does
not apply to service to pro se parties or
parties represented by a non-APOauthorized representative.
(iv) Parties must still take active steps
to serve pro se parties BPI documents
containing only the pro se party’s BPI
and serve parties represented by a nonAPO-authorized representative
documents containing only that party’s
BPI, consistent with § 351.306(c)(2).
However, E&C is temporarily modifying
the electronic service provision under
paragraph (f)(1)(ii) of this section, so
that a pro se party may give consent to
another interested party to serve a
document electronically on that pro se
party only, provided that the document
only contains the pro se party’s BPI.
Such a document must not contain the
BPI of other parties. In addition, a party
represented by a non-APO-authorized
representative may give consent to
another interested party to serve a
document electronically on that nonAPO-authorized representative only,
provided that the document only
contains the BPI of the party
represented by that non-APO-authorized
representative. Such a document must
not contain the BPI of other parties. If
such consent is given, then the serving
party’s APO-authorized representative
may serve the submission on that party
via electronic transmission with that
recipient’s consent.
(v) Exceptions. Notwithstanding
paragraphs (f)(4)(i) through (iv) of this
section, the following types of
submissions and scenarios require the
normal means of service as required by
this paragraph (f):
(A) Requests for administrative
review, new shipper review, changed
circumstances review and expedited
review.
(B) Requests for scope ruling or anticircumvention inquiry.
[FR Doc. 2020–06306 Filed 3–24–20; 4:15 pm]
BILLING CODE 3510–DS–P
VerDate Sep<11>2014
15:56 Mar 25, 2020
Jkt 250001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
21 CFR Parts 1, 117, and 507
[Docket No. FDA–2020–D–1108]
Temporary Policy Regarding
Preventive Controls and Foreign
Supplier Verification Programs Food
Supplier Verification Onsite Audit
Requirements During the COVID–19
Public Health Emergency: Guidance
for Industry; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notification of availability.
SUMMARY: The Food and Drug
Administration (FDA, Agency, or we) is
announcing the availability of a final
guidance for industry entitled
‘‘Temporary Policy Regarding
Preventive Controls and FSVP Food
Supplier Verification Onsite Audit
Requirements During the COVID–19
Public Health Emergency.’’ The
guidance communicates the Agency’s
intention not to enforce certain onsite
audit requirements in three of our food
safety regulations in certain
circumstances related to the impact of
the coronavirus if other supplier
verification methods that are designed
to provide sufficient assurance that
hazards have been significantly
minimized or prevented are used
instead during the period of onsite audit
delay.
DATES: The announcement of the
guidance is published in the Federal
Register on March 26, 2020.
ADDRESSES: You may submit either
electronic or written comments on
Agency guidances at any time as
follows:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov will be
posted to the docket unchanged.
Because your comment will be made
public, you are solely responsible for
ensuring that your comment does not
include any confidential information
that you or a third party may not wish
to be posted, such as medical
information, your or anyone else’s
Social Security number, or confidential
business information, such as a
manufacturing process. Please note that
if you include your name, contact
information, or other information that
identifies you in the body of your
PO 00000
Frm 00006
Fmt 4700
Sfmt 4700
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2020–D–1108 for ‘‘Temporary Policy
Regarding Preventive Controls and
FSVP Food Supplier Verification Onsite
Audit Requirements During the COVID–
19 Public Health Emergency.’’ Received
comments will be placed in the docket
and, except for those submitted as
‘‘Confidential Submissions,’’ publicly
viewable at https://www.regulations.gov
or at the Dockets Management Staff
between 9 a.m. and 4 p.m., Monday
through Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
E:\FR\FM\26MRR1.SGM
26MRR1
Federal Register / Vol. 85, No. 59 / Thursday, March 26, 2020 / Rules and Regulations
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852.
You may submit comments on any
guidance at any time (see § 10.115(g)(5)
(21 CFR 10.115(g)(5))).
Submit written requests for single
copies of the guidance to the Office of
Food Safety, Center for Food Safety and
Applied Nutrition, Food and Drug
Administration (HFS–300), 5001
Campus Dr., College Park, MD 20740.
Send two self-addressed adhesive labels
to assist that office in processing your
request. See the SUPPLEMENTARY
INFORMATION section for electronic
access to the guidance.
FOR FURTHER INFORMATION CONTACT:
For questions relating to Current Good
Manufacturing Practices (CGMP),
Hazard Analysis, and Risk-Based
Preventive Controls for Human Food:
Jenny Scott, Center for Food Safety and
Applied Nutrition (HFS–300), Food and
Drug Administration, 5001 Campus Dr.,
College Park, MD 20740, 240–402–2166.
For questions relating to CGMP,
Hazard Analysis, and Risk-Based
Preventive Controls for Food for
Animals: Jeanette Murphy, Center for
Veterinary Medicine (HFV–200), Food
and Drug Administration, 7519 Standish
Pl., Rockville, MD 20855, 240–402–
6246.
For questions relating to Foreign
Supplier Verification Programs (FSVP)
for Importers of Food for Humans and
Animals: Charlotte Christin, Office of
Food Policy and Response, Food and
Drug Administration, 10903 New
Hampshire Ave., Silver Spring, MD
20993–0002, 301–796–7526.
SUPPLEMENTARY INFORMATION:
lotter on DSKBCFDHB2PROD with RULES
I. Background
We are announcing the availability of
a guidance for industry entitled
‘‘Temporary Policy Regarding
Preventive Controls and FSVP Food
Supplier Verification Onsite Audit
Requirements During the COVID–19
Public Health Emergency.’’ We are
issuing this guidance consistent with
our good guidance practices regulation
VerDate Sep<11>2014
15:56 Mar 25, 2020
Jkt 250001
(§ 10.115). In accordance with
§ 10.115(g)(2), we are implementing the
guidance immediately because we have
determined that prior public
participation is not feasible or
appropriate. Although the guidance
document is immediately in effect, FDA
will accept comments at any time. The
guidance represents the current thinking
of FDA on this topic. It does not
establish any rights for any person and
is not binding on FDA or the public.
You can use an alternative approach if
it satisfies the requirements of the
applicable statutes and regulations.
This guidance document concerns
certain supplier verification
requirements contained in three of the
seven foundational regulations that we
have established in Title 21 of the Code
of Federal Regulations (CFR) as part of
our implementation of the FDA Food
Safety Modernization Act (Pub. L. 111–
353). The three final regulations are
entitled ‘‘Current Good Manufacturing
Practice, Hazard Analysis, and RiskBased Preventive Controls for Human
Food’’ (part 117 (21 CFR part 117))
(https://www.fda.gov/food/
guidanceregulation/fsma/
ucm334115.htm); ‘‘Current Good
Manufacturing Practice, Hazard
Analysis, and Risk-Based Preventive
Controls for Food for Animals’’ (part
507 (21 CFR part 507)) (https://
www.fda.gov/food/guidanceregulation/
fsma/ucm366510.htm); and ‘‘Foreign
Supplier Verification Programs for
Importers of Food for Humans and
Animals’’ (part 1, subpart L (21 CFR part
1, subpart L)) (https://www.fda.gov/
food/guidanceregulation/fsma/
ucm361902.htm). In brief, each of these
regulations requires a supply-chain or
supplier verification program in certain
circumstances when a supplier is
controlling a hazard. In addition, each
of these regulations provides for onsite
audits of suppliers under certain
circumstances to verify that the hazard
is being controlled.
The purpose of the guidance is to
state the current intent of FDA, in
certain circumstances related to the
impact of the coronavirus, not to enforce
requirements in the three regulations to
conduct onsite audits of food suppliers
when other supplier verification
methods are used to provide sufficient
assurance that hazards have been
significantly minimized or prevented,
during the period of onsite audit delay.
II. Paperwork Reduction Act of 1995
This guidance refers to previously
approved FDA collections of
information. These collections of
information are subject to review by the
Office of Management and Budget
PO 00000
Frm 00007
Fmt 4700
Sfmt 4700
17009
(OMB) under the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501–3521). The
collections of information in part 117
have been approved under OMB control
number 0910–0751. The collections of
information in part 507 have been
approved under OMB control number
0910–0789. The collections of
information in part 1, subpart L have
been approved under OMB control
number 0910–0752.
III. Electronic Access
Persons with access to the internet
may obtain the guidance at either
https://www.fda.gov/FoodGuidances or
https://www.regulations.gov. Use the
FDA website listed in the previous
sentence to find the most current
version of the guidance.
Dated: March 17, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020–05897 Filed 3–25–20; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF THE INTERIOR
Bureau of Indian Affairs
25 CFR Part 30
[190D0102DR/DS5A300000/
DR.5A311.IA000119]
RIN 1076–AF13
Standards, Assessments, and
Accountability System
Bureau of Indian Affairs,
Interior.
ACTION: Final rule.
AGENCY:
SUMMARY: The Bureau of Indian
Education (BIE) is finalizing a rule
developed using a negotiated
rulemaking process, as required by the
Elementary and Secondary Education
Act of 1965 (ESEA or the Act), as
amended by 2015 Every Student
Succeeds Act (ESSA), for
implementation of the Secretary of the
Interior’s (Secretary) responsibility to
establish requirements for standards,
assessments, and an accountability
system for BIE-funded schools.
DATES: This rule is effective on April 27,
2020.
FOR FURTHER INFORMATION CONTACT:
Elizabeth Appel, Director, Office of
Regulatory Affairs & Collaborative
Action, (202) 273–4680;
elizabeth.appel@bia.gov.
SUPPLEMENTARY INFORMATION:
I. Background
II. Overview of the Final Rule
III. Public Comments on the Proposed Rule
and Responses to Comments
E:\FR\FM\26MRR1.SGM
26MRR1
Agencies
[Federal Register Volume 85, Number 59 (Thursday, March 26, 2020)]
[Rules and Regulations]
[Pages 17008-17009]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-05897]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Parts 1, 117, and 507
[Docket No. FDA-2020-D-1108]
Temporary Policy Regarding Preventive Controls and Foreign
Supplier Verification Programs Food Supplier Verification Onsite Audit
Requirements During the COVID-19 Public Health Emergency: Guidance for
Industry; Availability
AGENCY: Food and Drug Administration, HHS.
ACTION: Notification of availability.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA, Agency, or we) is
announcing the availability of a final guidance for industry entitled
``Temporary Policy Regarding Preventive Controls and FSVP Food Supplier
Verification Onsite Audit Requirements During the COVID-19 Public
Health Emergency.'' The guidance communicates the Agency's intention
not to enforce certain onsite audit requirements in three of our food
safety regulations in certain circumstances related to the impact of
the coronavirus if other supplier verification methods that are
designed to provide sufficient assurance that hazards have been
significantly minimized or prevented are used instead during the period
of onsite audit delay.
DATES: The announcement of the guidance is published in the Federal
Register on March 26, 2020.
ADDRESSES: You may submit either electronic or written comments on
Agency guidances at any time as follows:
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand Delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2020-D-1108 for ``Temporary Policy Regarding Preventive Controls
and FSVP Food Supplier Verification Onsite Audit Requirements During
the COVID-19 Public Health Emergency.'' Received comments will be
placed in the docket and, except for those submitted as ``Confidential
Submissions,'' publicly viewable at https://www.regulations.gov or at
the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through
Friday.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For
[[Page 17009]]
more information about FDA's posting of comments to public dockets, see
80 FR 56469, September 18, 2015, or access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.
You may submit comments on any guidance at any time (see Sec.
10.115(g)(5) (21 CFR 10.115(g)(5))).
Submit written requests for single copies of the guidance to the
Office of Food Safety, Center for Food Safety and Applied Nutrition,
Food and Drug Administration (HFS-300), 5001 Campus Dr., College Park,
MD 20740. Send two self-addressed adhesive labels to assist that office
in processing your request. See the SUPPLEMENTARY INFORMATION section
for electronic access to the guidance.
FOR FURTHER INFORMATION CONTACT:
For questions relating to Current Good Manufacturing Practices
(CGMP), Hazard Analysis, and Risk-Based Preventive Controls for Human
Food: Jenny Scott, Center for Food Safety and Applied Nutrition (HFS-
300), Food and Drug Administration, 5001 Campus Dr., College Park, MD
20740, 240-402-2166.
For questions relating to CGMP, Hazard Analysis, and Risk-Based
Preventive Controls for Food for Animals: Jeanette Murphy, Center for
Veterinary Medicine (HFV-200), Food and Drug Administration, 7519
Standish Pl., Rockville, MD 20855, 240-402-6246.
For questions relating to Foreign Supplier Verification Programs
(FSVP) for Importers of Food for Humans and Animals: Charlotte
Christin, Office of Food Policy and Response, Food and Drug
Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002,
301-796-7526.
SUPPLEMENTARY INFORMATION:
I. Background
We are announcing the availability of a guidance for industry
entitled ``Temporary Policy Regarding Preventive Controls and FSVP Food
Supplier Verification Onsite Audit Requirements During the COVID-19
Public Health Emergency.'' We are issuing this guidance consistent with
our good guidance practices regulation (Sec. 10.115). In accordance
with Sec. 10.115(g)(2), we are implementing the guidance immediately
because we have determined that prior public participation is not
feasible or appropriate. Although the guidance document is immediately
in effect, FDA will accept comments at any time. The guidance
represents the current thinking of FDA on this topic. It does not
establish any rights for any person and is not binding on FDA or the
public. You can use an alternative approach if it satisfies the
requirements of the applicable statutes and regulations.
This guidance document concerns certain supplier verification
requirements contained in three of the seven foundational regulations
that we have established in Title 21 of the Code of Federal Regulations
(CFR) as part of our implementation of the FDA Food Safety
Modernization Act (Pub. L. 111-353). The three final regulations are
entitled ``Current Good Manufacturing Practice, Hazard Analysis, and
Risk-Based Preventive Controls for Human Food'' (part 117 (21 CFR part
117)) (https://www.fda.gov/food/guidanceregulation/fsma/ucm334115.htm);
``Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based
Preventive Controls for Food for Animals'' (part 507 (21 CFR part 507))
(https://www.fda.gov/food/guidanceregulation/fsma/ucm366510.htm); and
``Foreign Supplier Verification Programs for Importers of Food for
Humans and Animals'' (part 1, subpart L (21 CFR part 1, subpart L))
(https://www.fda.gov/food/guidanceregulation/fsma/ucm361902.htm). In
brief, each of these regulations requires a supply-chain or supplier
verification program in certain circumstances when a supplier is
controlling a hazard. In addition, each of these regulations provides
for onsite audits of suppliers under certain circumstances to verify
that the hazard is being controlled.
The purpose of the guidance is to state the current intent of FDA,
in certain circumstances related to the impact of the coronavirus, not
to enforce requirements in the three regulations to conduct onsite
audits of food suppliers when other supplier verification methods are
used to provide sufficient assurance that hazards have been
significantly minimized or prevented, during the period of onsite audit
delay.
II. Paperwork Reduction Act of 1995
This guidance refers to previously approved FDA collections of
information. These collections of information are subject to review by
the Office of Management and Budget (OMB) under the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501-3521). The collections of information in
part 117 have been approved under OMB control number 0910-0751. The
collections of information in part 507 have been approved under OMB
control number 0910-0789. The collections of information in part 1,
subpart L have been approved under OMB control number 0910-0752.
III. Electronic Access
Persons with access to the internet may obtain the guidance at
either https://www.fda.gov/FoodGuidances or https://www.regulations.gov. Use the FDA website listed in the previous
sentence to find the most current version of the guidance.
Dated: March 17, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-05897 Filed 3-25-20; 8:45 am]
BILLING CODE 4164-01-P